Kindling Model of Recurrent Affective Disorders – Robert M. Post

The conceptual architecture of modern psychopathology owes much of its sophistication to the realization that psychiatric illnesses are not static, immutable states of neurochemical imbalance, but dynamic, evolving neurobiological trajectories. For decades following the mid-twentieth-century psychopharmacological revolution, affective disorders—specifically unipolar major depression and bipolar affective disorder—were predominantly understood through simplistic monoaminergic models. These hypotheses posited that episodic disturbances in mood, cognition, and vegetative functioning stemmed from localized deficits or excesses of serotonin, norepinephrine, or dopamine. While these models successfully catalyzed the synthesis of first- and second-generation psychotropic medications, they failed fundamentally to account for the longitudinal course of affective illness: the ominous clinical reality that episodes tend to become more frequent, more severe, more spontaneous, and increasingly refractory to conventional interventions as patients age.

In the late 1970s and early 1980s, Dr. Robert M. Post and his colleagues at the National Institute of Mental Health (NIMH) introduced a revolutionary paradigm that fundamentally altered psychiatric epistemology: the kindling and behavioral sensitization model of recurrent affective disorders. Drawing upon classic neurophysiological research into experimental epileptogenesis, Post posited that recurrent mood episodes leave lasting neurochemical, electrophysiological, and genomic scars within corticolimbic networks. Through iterative cycles of stress-induced or pharmacologically mediated neural activation, the central nervous system undergoes a profound transformation. Subthreshold perturbations eventually coalesce into full-blown clinical episodes, and the environmental stressors required to precipitate early episodes gradually yield to endogenous, autonomous rhythmicity.

The kindling hypothesis bridged the longstanding chasm between neurology and psychiatry, between psychological trauma and molecular biology, and between naturalistic course observations and targeted psychopharmacology. It provided an empirical and theoretical foundation for understanding why early intervention is critical, why certain anticonvulsants possess mood-stabilizing properties, and how repetitive affective episodes induce progressive neurobiological changes. The following treatise provides an exhaustive examination of Post’s kindling model: tracing its historical origins, detailing its electrophysiological and molecular substrates, evaluating its clinical phenomenology, exploring its modern therapeutic and staging implications, and synthesizing contemporary neuroimaging, multi-omics, and connectomic insights that validate and extend this landmark theory.

1. Introduction to the Kindling Hypothesis in Affective Illness

1.1 Historical Emergence of Post’s Conceptual Framework

The genesis of Robert M. Post’s kindling framework arose from a persistent paradox observed in psychiatric clinical practice and longitudinal research during the 1970s. While Emil Kraepelin had noted in his classic 1899 natural history descriptions that manic-depressive illness was characterized by a cyclic course with a distinct tendency toward interval compression, twentieth-century psychiatry remained dominated by static models. Neurochemical hypotheses assumed that mood states were direct readouts of instantaneous synaptic amine concentrations, treating each affective episode as an isolated, self-contained event that resolved completely without altering the baseline vulnerability of the central nervous system.

Post and his research group at the NIMH Biological Psychiatry Branch recognized that these cross-sectional paradigms were utterly inadequate for explaining the longitudinal evolution of affective disease. Clinical observations repeatedly revealed that patients diagnosed with recurrent unipolar depression or bipolar disorder experienced a progressive acceleration of cycle frequency over their lifetimes. The asymptomatic periods between affective episodes—termed “well intervals”—systematically contracted following each subsequent relapse. Furthermore, the clinical manifestations of the illness frequently deteriorated over time, evolving from discrete, fully remitting episodes of euphoric mania or melancholic depression into dysphoric mania, mixed states, and rapid cycling forms.

To resolve this explanatory deficit, Post turned to experimental neurophysiology, specifically the kindling phenomena originally characterized by Graham Goddard in the late 1960s. Post recognized that the brain possesses memory-like mechanisms for pathological activity. Just as repetitive, subthreshold electrical stimulation could permanently alter neuronal responsivity and generate spontaneous motor convulsions in animal models, repetitive affective episodes might represent an analogous process within the emotional and cognitive circuits of the limbic system. The initial reception of this idea within biological psychiatry was marked by equal parts intrigue and skepticism; bridging the gap between grand mal motor seizures and complex, subjective human mood dysregulation demanded rigorous mechanistic evidence, which Post spent the subsequent decades systematically gathering.

1.2 Fundamental Premise: From Triggered to Autonomous Episodes

The foundational insight of the kindling model lies in the progressive decoupling of affective episodes from environmental precipitating events. In the nascent stages of recurrent affective illness, the initial depressive or manic episodes are almost universally preceded by severe, identifiable psychosocial stressors. These severe life events—such as catastrophic interpersonal loss, severe physical threat, profound professional failure, or major disruptions to social and circadian rhythms—serve as high-amplitude triggers that overwhelm normal allostatic coping mechanisms in genetically or developmentally vulnerable individuals.

However, as the clinical course progresses and the individual experiences multiple iterations of affective relapse, a critical phenomenological shift occurs: the statistical association between major psychosocial stressors and the onset of new episodes weakens precipitously. Patients begin to experience full-blown melancholic, manic, or mixed episodes following trivial daily hassles, minor schedule disruptions, or, ultimately, in the complete absence of any identifiable external stressor whatsoever. The illness transitions from a reactive, environmentally contingent process to an endogenous, self-perpetuating, and autonomous neurobiological state.

This transition from triggered to autonomous episodes forces a radical conceptualization of recurrent affective disorders as active neurobiological processes rather than static diatheses. Affective episodes themselves are inherently toxic to neural architecture; each episode leaves behind a neuroplastic footprint that lowers the threshold for subsequent episode induction. Consequently, the long-term management of affective disorders cannot be conceptualized merely as the acute, episodic suppression of symptoms as they emerge. Instead, the kindling framework establishes an urgent prophylactic mandate: pharmacotherapy and psychotherapeutic interventions must be implemented aggressively and maintained continuously during the earliest phases of the disease to prevent the cellular and synaptic adaptations that drive the transition to autonomy.

1.3 Core Nomenclature and Definitions in Kindling Theory

Precise application of the kindling framework requires clear demarcation of its core neurobiological and clinical nomenclature. Central to Post’s theoretical synthesis is the critical distinction between electrophysiological kindling and behavioral sensitization. While both phenomena describe progressive, long-lasting increases in neural responsivity following repetitive stimulation, they operate through divergent primary mechanisms and manifest via distinct clinical phenotypes. Electrophysiological kindling refers specifically to the process whereby repeated, intermittent, subthreshold electrical or chemical stimulation of specific brain regions results in progressively prolonged afterdischarges, culminating in spontaneous, self-propagating electrographic and clinical seizure activity.

In contrast, behavioral sensitization—often referred to as reverse tolerance—describes the progressive augmentation of a behavioral, motor, or physiological response to the repeated, intermittent administration of a constant pharmacological agent (such as psychostimulants like cocaine or amphetamine) or to the repetitive exposure to heterotypic environmental stressors. In the clinical context of affective illness, sensitization explains the heightened vulnerability and exaggerated neurochemical reactivity to increasingly minor stressors, whereas kindling provides the physiological template for the eventual development of episode autonomy, rapid cycling, and spontaneous neurochemical storms that occur without any external stimulus.

Furthermore, kindling theory requires a granular parsing of disease metrics: episode frequency (the number of discrete affective episodes occurring within a specified epoch), episode duration (the temporal length of active syndromal symptomatology), and symptom severity (the depth of neurovegetative, cognitive, and psychotic dysfunction). Neuroplastic vulnerability describes the progressive reduction in the biophysical and chemical activation threshold required to recruit corticolimbic networks into an affective episode. When this threshold drops to zero, the patient achieves “episode autonomy”—a state often characterized by treatment-refractory rapid cycling, high rates of chronicity, severe neurocognitive impairment, and marked inter-episode affective instability.

2. Electrophysiological Foundations: Goddard’s Seizure Paradigm to Neuropsychiatry

2.1 Graham Goddard’s Classical Kindling Experiments

The mechanical underpinnings of the kindling model originate in the landmark work of Canadian psychologist Graham V. Goddard and his colleagues at the University of Waterloo in 1969. While investigating the neural substrates of learning and memory, Goddard discovered that delivering mild, low-intensity electrical currents to the brains of rats produced startling and unforeseen neurophysiological consequences. Goddard applied an electrical stimulus that was explicitly “subthreshold”—meaning its amplitude and frequency were entirely insufficient to evoke any observable motor, behavioral, or electrographic seizure activity upon its initial administration.

However, when Goddard delivered this exact same low-intensity electrical pulse intermittently—typically once daily for several seconds—the stimulated brain tissue underwent a dramatic transformation. Over days and weeks, the subthreshold stimulus began to evoke localized electrical afterdischarges on electroencephalographic (EEG) recordings. With successive daily stimulations, these afterdischarges grew progressively longer in duration, higher in amplitude, and began to propagate anatomically beyond the localized stimulation site into adjacent and contralateral neural structures. Concurrently, the animals began to manifest progressive motor alterations, classically categorized by Racine into a five-stage scale extending from subtle facial clonus and head nodding to rearing, bilateral forelimb clonus, and ultimate loss of postural equilibrium in generalized tonic-clonic convulsions.

Crucially, Goddard demonstrated that this kindled transformation was essentially permanent. If an animal was fully kindled and then left un-stimulated for months or even years, the re-administration of that same weak electrical stimulus immediately elicited a full, generalized motor convulsion. Most profound of all, if the intermittent stimulation was continued beyond the initial generalization stage, the animals eventually developed “spontaneous” seizures—epileptic events that erupted intrinsically in the absolute absence of any applied electrical stimulus. Strikingly, histology revealed that this permanent hyper-excitability occurred without gross structural necrosis or mechanical tissue destruction, indicating that kindling represented a profound, enduring functional reorganization of synaptic efficacy and neural plasticity.

2.2 Bridging Epilepsy and Affective Psychopathology

The conceptual bridge spanning Goddard’s electrical seizure models and Post’s psychopathological framework was forged through the observation of shared clinical, neurochemical, and anatomical features between temporal lobe epilepsy (TLE) and recurrent affective illness. For over a century, clinical neurologists and psychiatrists had documented that individuals suffering from complex partial seizures or temporal lobe focus epilepsy displayed profound interictal psychiatric manifestations. These patients exhibited high rates of paroxysmal affective dysregulation, unprovoked surges of terror or euphoric ecstasy, profound melancholic episodes, paranoia, and chronic alterations in personality structure—a constellation historically designated as the Gastaut-Geschwind syndrome.

Post realized that the limbic system, which exhibits the lowest electrical threshold for kindling in the mammalian brain, is precisely the neuroanatomical circuit that governs human affective homeostasis, stress reactivity, and emotional valence. Specifically, structures such as the amygdaloid complex, the hippocampus, the entorhinal cortex, and the medial prefrontal cortex are exceptionally susceptible to both electrophysiological kindling and stress-induced remodeling. If electrical stimulation of the amygdala could kindle motor convulsions by recruiting motor networks, Post reasoned by analogy that repetitive psychological stress or endogenous affective episodes could kindle emotional circuits by recruiting paralimbic, striatal, and prefrontal networks.

This theoretical leap posited a model of non-convulsive kindling. Rather than manifesting as overt motor convulsions, kindling within affective circuits manifests as episodes of affective turmoil: severe depressive prostration, agitated dysphoria, or psychomotor acceleration. The shared phenomenology of paroxysmal onset, episodic recurrence, cyclical rhythmicity, and interictal behavioral alterations between temporal lobe epilepsy and bipolar disorder strongly suggested that both clinical entities share an underlying biophysical substrate: a progressive, activity-dependent enhancement of neuronal excitability within vulnerable corticolimbic networks.

2.3 Subthreshold Neurochemical Perturbations

The translation of electrophysiological kindling into an affective paradigm necessitates an understanding of how non-electrical, psychological stimuli can alter neural excitability at the synaptic level. In the human central nervous system, psychosocial trauma, environmental deprivation, and acute psychological threats do not deliver raw electrical milliamperes to brain tissue; instead, they trigger intense, repetitive neurochemical and endocrine cascades. Severe stress evokes massive, paroxysmal releases of excitatory amino acids (principally glutamate), monoamines, corticotropin-releasing hormone (CRH), and adrenomedullary catecholamines into corticolimbic synapses.

In individuals possessing genetic or neurodevelopmental vulnerabilities, these iterative neurochemical surges act as the biological equivalent of Goddard’s subthreshold electrical pulses. Each burst of stress-induced glutamate release leads to transient depolarizations that, while insufficient to cause immediate gross tissue damage, generate cumulative alterations in synaptic strength. The post-synaptic densities within the basolateral amygdala and hippocampal CA1/CA3 regions undergo a gradual reduction in the magnitude of endogenous inhibitory post-synaptic potentials (IPSPs), mediated primarily by gamma-aminobutyric acid (GABA), alongside a progressive amplification of excitatory post-synaptic potentials (EPSPs), mediated by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-aspartate (NMDA) receptors.

Over time, this continuous neurochemical remodeling lowers the activation threshold of the entire circuit. Limbic neurons become hyper-responsive to ambient neurotransmitter fluctuations. What was initially an imperceptible micro-stressor begins to trigger disproportionately large electrophysiological bursts. The corticolimbic network becomes “kindled” at the chemical level: transient functional shifts in ionic conductance, receptor phosphorylation, and local circuit disinhibition steadily consolidate into permanent structural reorganization, locking the neuronal circuit into a persistent state of pathological hyper-excitability that lowers the barrier to future clinical episode induction.

3. Behavioral Sensitization versus Electrophysiological Kindling

3.1 Mechanisms of Behavioral Sensitization

While electrophysiological kindling provides an elegant mechanism for understanding seizure progression and episode autonomy, Robert M. Post recognized that it could not independently account for the complex phenomenology of affective disorders. To complete the conceptual architecture, Post integrated the paradigm of behavioral sensitization—a neurobiological process discovered and extensively characterized through psychomotor stimulant models. When experimental animals are administered repeated, intermittent, low-to-moderate doses of psychostimulants such as cocaine or d-amphetamine, they do not develop tolerance to the drug’s locomotor-activating and stereotypic properties; instead, they develop progressive, enduring augmentation of these behavioral responses.

The neurobiology of behavioral sensitization centers largely on the ascending mesocorticolimbic and nigrostriatal dopaminergic projections, originating in the ventral tegmental area (VTA) and substantia nigra pars compacta, and terminating in the nucleus accumbens, amygdala, and prefrontal cortex. Sensitization involves a two-phase process: induction and expression. The induction phase occurs primarily within the VTA, where intermittent drug exposure stimulates transient bursts of somatodendritic dopamine release, activating dopamine D1 receptors and local NMDA glutamate receptors. This triggers downstream intracellular signaling cascades, including calcium/calmodulin-dependent protein kinase II (CaMKII) and extracellular signal-regulated kinase (ERK), which drive long-term neuroadaptations.

The expression phase of sensitization is mediated within the forebrain terminal fields, particularly the nucleus accumbens and prefrontal cortex. Here, chronic adaptations manifest as enhanced glutamate release from corticostriatal afferents, increased cell-surface expression of AMPA receptor GluA1 subunits, and hypersensitivity of post-synaptic dopamine D2 and D3 signaling cascades. Furthermore, behavioral sensitization displays extensive cross-sensitization with environmental stress. An animal sensitized to chronic intermittent physical restraint or maternal separation will exhibit an exaggerated behavioral and dopaminergic response upon its initial exposure to amphetamine, and conversely, animals pre-exposed to psychostimulants manifest hyper-reactive neuroendocrine and behavioral responses to acute psychological stressors. Peptidergic networks, particularly corticotropin-releasing hormone (CRH), dynorphin, and neurotensin, further modulate these sensitized pathways, entrenching persistent hyper-reactivity.

3.2 Comparative Analysis: Kindling versus Sensitization

To rigorously apply these paradigms to psychopathology, it is essential to conduct a granular comparative analysis contrasting the biophysical, temporal, and anatomical profiles of kindling and sensitization. Post formulated a dual-process model that delineated these differences while demonstrating their clinical convergence:

• Primary Dependent Variable: Electrophysiological kindling is fundamentally an all-or-nothing, threshold-governed electrographic phenomenon characterized by the emergence of afterdischarges, paroxysmal depolarizing shifts, and convulsive or non-convulsive electrical seizures. Behavioral sensitization, by contrast, is a continuously graded, parametric behavioral amplification characterized by heightened motor, behavioral, cognitive, or neuroendocrine output in response to a constant environmental or pharmacological challenge.
• Temporal Evolution and Reversibility: Kindling generally requires rigid, periodic pacing of stimuli to develop; however, once full kindling and spontaneous seizures are established, the electrophysiological hyper-responsiveness is essentially permanent and irreversible without aggressive pharmacological suppression. Sensitization develops rapidly following even brief intermittent exposures and can persist for months or years, but it often exhibits context-dependency (sensitization is expressed most potently in the physical environment where the stimulus was originally experienced) and can, under certain conditions, undergo extinction or partial decay.
• Primary Neuroanatomical Substrates: While kindling exhibits its lowest thresholds within the limbic structures of the temporal lobe—specifically the periamygdaloid complex, entorhinal cortex, and hippocampus—sensitization is primarily orchestrated within the mesocorticolimbic dopaminergic circuitry, spanning the VTA, the ventral striatum (nucleus accumbens core and shell), and the medial prefrontal cortex.
• Pharmacological Responsivity: Kindled seizure propagation is powerfully suppressed by classical anticonvulsants that block voltage-gated sodium channels or enhance GABAergic tone (e.g., carbamazepine, valproate, lamotrigine), whereas behavioral sensitization is often attenuated by dopamine receptor antagonists, NMDA receptor antagonists (which block the induction phase), and neurotropic stabilizing agents.

3.3 Relevance to Affective Episode Induction

The clinical power of Robert M. Post’s theoretical model resides in the elegant synthesis of both behavioral sensitization and electrophysiological kindling into a single, unified longitudinal trajectory of affective illness. Post demonstrated that these two distinct neuroplastic processes operate sequentially and synergistically across the lifetime of the psychiatric patient, explaining different phases of clinical deterioration.

In this dual-process framework, behavioral sensitization acts as the driving engine of the early-to-intermediate stages of affective illness. Sensitization mechanisms explain why patients display an ever-increasing psychological and neurobiological vulnerability to stressors over time. When an individual encounters severe trauma in childhood or early adulthood, the mesocorticolimbic and corticolimbic networks become sensitized. Consequently, subsequent life events do not need to be as catastrophic as the initial trigger; rather, due to cross-sensitization, progressively milder environmental stressors, interpersonal conflicts, or sleep-wake cycle disruptions become capable of releasing equivalent surges of corticolimbic neurotransmitters, ultimately precipitating full syndromal major depressive or hypomanic episodes.

As episodes continue to recur, the neurobiological process transitions into the domain of electrophysiological kindling. The recurrent, sensitized neurochemical and metabolic storms that characterize acute affective episodes act as cumulative, subthreshold limbic “shocks.” Over repeated iterations, these episodes permanently alter the synaptic wiring, membrane excitability, and gene expression profiles of the amygdalo-hippocampal and prefrontal networks. Once the kindling process crosses the critical threshold, the illness achieves functional independence from external triggers: spontaneous episodes erupt autonomously. Furthermore, this dual-process model clarifies the catastrophic synergy observed clinically between substance abuse and affective disorders. Patients with a bipolar diathesis who abuse cocaine or amphetamines rapidly accelerate their illness trajectory, driving both behavioral cross-sensitization (escalating paranoia, agitation, and mania) and electrophysiological kindling (hastening the onset of rapid cycling and treatment refractoriness).

4. Clinical Phenomenology of Recurrent Affective Episodes

4.1 Longitudinal Course and Episode Acceleration

The clinical course of recurrent affective illness, when left unmitigated by prophylactic interventions, provides compelling empirical validation for the kindling hypothesis. Modern naturalistic and longitudinal studies—most notably those conducted by the National Institute of Mental Health Collaborative Depression Study, Jules Angst’s Zurich cohort, and Paul Grof’s longitudinal bipolar registries—have robustly confirmed what Emil Kraepelin originally documented: affective illness is intrinsically characterized by cycle acceleration.

The temporal architecture of recurrent affective disorders reveals that the interval between the first and second lifetime episode is typically the longest well interval the patient will ever experience, often spanning several years. However, the duration of the subsequent well intervals (the inter-episode periods) progressively shortens across the second, third, fourth, and fifth episodes. Eventually, the cycle length—defined as the time from the onset of one affective episode to the onset of the next—stabilizes at an abbreviated, chronic plateau. This progressive cycle compression occurs in both unipolar major depressive disorder and bipolar disorder, although the acceleration curve is notoriously steeper and more pronounced in bipolar illness, particularly bipolar I disorder.

Naturalistic historical data compiled by Post demonstrated that prior to the advent of modern mood stabilizers, the median duration of well intervals dropped from approximately 36 to 48 months following the initial episode to under 12 months following the fourth or fifth episode. This systematic shortening of well intervals occurs independently of the patient’s chronological age at onset, confirming that cycle acceleration is not simply an artifact of biological aging, but is an illness-driven, episode-dependent process. Every single episode of depression or mania appears to function as an independent risk factor for future episodes, consolidating the pathological neurocircuitry in a manner directly analogous to experimental kindling paradigms.

4.2 The Transition from Reactive to Endogenous Episodes

One of the most clinically transformative contributions of Post’s model is its capacity to account for the shifting etiology of individual affective episodes across a patient’s lifespan. In the nascent phases of unipolar or bipolar illness, the association between life stress and episode onset is unmistakable. Groundbreaking epidemiological research by George Brown, Tirril Harris, and later Kenneth Kendler systematically demonstrated that the first lifetime major depressive episode is preceded by severe, high-threat life events in up to 80% to 90% of cases. These stressors are typically acute, major life crises characterized by severe loss, humiliation, or severe interpersonal entrapment.

However, when researchers map life events against later episodes in the longitudinal sequence (e.g., episode five, eight, or twelve), a completely different epidemiological picture emerges. The prevalence of severe life events preceding episode onset declines precipitously, dropping to levels that are indistinguishable from baseline community control samples. Minor, normative daily hassles—such as transient workplace deadlines or mild marital disagreements—frequently appear in temporal proximity to late-stage episodes, or the episodes materialize entirely de novo out of clear psychological skies, devoid of any contextual environmental contingency.

This empirical trajectory—the progressive loss of stress-precipitated episode onset—is one of the most robust findings in psychiatric epidemiology. It accounts for the classic historical diagnostic dichotomy between “reactive” (exogenous) and “endogenous” affective disorders. Rather than representing two fundamentally distinct, genetically segregated subtypes of illness, Post demonstrated that reactive and endogenous presentations represent different developmental stages of the exact same recurrent disease process. Early in the illness, the brain requires massive environmental perturbations to trigger the neurochemical cascade of an episode (reactive stage); late in the illness, the kindled and sensitized brain spontaneously fires into an affective episode via endogenous pacemaker destabilization (autonomous stage).

4.3 Development of Rapid and Ultra-Rapid Cycling

The ultimate clinical manifestation of an advanced, fully kindled affective pathology is the emergence of rapid cycling, defined by the DSM-5 as the occurrence of at least four discrete affective episodes (depressive, manic, hypomanic, or mixed) within a continuous 12-month period. In its most extreme iterations, the phenomenon advances into ultra-rapid cycling (where episodes shift every few days or weeks) or ultradian cycling (where distinct affective switches occur within a single 24-hour period, often displaying intractable, agitated mixed phenomenology).

From the perspective of kindling theory, rapid cycling represents a state of catastrophic circuit destabilization. The endogenous circadian, infradian, and neuroendocrine pacemakers that govern normal biological rhythms lose their regulatory coupling. The corticolimbic networks become so hyper-excitable that the termination of one affective phase (e.g., mania) inherently triggers an immediate rebound into the opposing polarity (e.g., severe depression), completely bypassing the physiological homeostatic state of euthymia. The brain is caught in an oscillating, self-sustaining attractor state, functionally equivalent to the spontaneous, unprompted seizures seen in Goddard’s fully kindled animals.

Crucially, the kindling framework illuminates the mechanisms driving iatrogenic destabilization. The indiscriminate administration of tricyclic antidepressants or selective serotonin reuptake inhibitors (SSRIs) to individuals with kindled bipolar diatheses frequently accelerates cycle frequency, converting stable episodic illness into malignant rapid cycling. The exogenous serotonergic and noradrenergic stimulation delivered by these agents acts as an additional pharmacological kindling or sensitizing influence upon an already fragile neural substrate. The prognostic implications of rapid cycling are exceedingly grave: it is associated with marked treatment refractoriness, profound cognitive decline, dramatically elevated rates of suicide attempts, and severe global functional disability.

5. Neurobiological Substrates of the Kindling Cascade

5.1 Glutamatergic Excitotoxicity and NMDA Receptor Plasticity

At the intimate level of the synapse, the biophysical engine that drives both electrophysiological kindling and affective episode recurrence is the glutamatergic neurotransmitter system. Glutamate is the principal excitatory neurotransmitter in the mammalian central nervous system, mediating over 80% of all synaptic transmissions in the cerebral cortex and limbic system. Under physiological conditions, glutamate release is tightly compartmentalized and regulated. However, during states of intense affective hyper-arousal, psychological trauma, or mania, massive surges of glutamate are discharged into the synaptic cleft across the amygdala, hippocampus, and prefrontal networks.

This persistent, excessive synaptic glutamate hyper-activates post-synaptic ionotropic glutamate receptors, specifically the N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor complexes. Sustained stimulation of NMDA receptors removes the voltage-dependent magnesium ($Mg^{2+}$) block, triggering a massive, pathological influx of extracellular calcium ions ($Ca^{2+}$) into the post-synaptic dendritic shaft. This calcium overload initiates a lethal enzymatic cascade, hyper-activating calcium-dependent proteases such as calpains, triggering calcineurin activity, and activating nitric oxide synthase (nNOS), leading to the generation of cytotoxic reactive nitrogen species (RNS) and reactive oxygen species (ROS).

Concurrently, the astrocytic architecture responsible for clearing extracellular glutamate becomes compromised. Glial fibrillary acidic protein (GFAP)-positive astrocytes downregulate their excitatory amino acid transporters (specifically EAAT1 and EAAT2/GLT-1), impairing their capacity to rapidly reuptake synaptic glutamate and convert it safely into glutamine. As extracellular clearance fails, ambient glutamate concentrations remain elevated, sustaining a toxic loop. This chronic excitotoxic environment drives pathological long-term potentiation (LTP) mechanisms at aberrant synaptic sites, permanently strengthening pathological excitatory pathways while pruning healthy dendritic spines. The structural and functional wiring of the affective circuit is thus remodeled to favor spontaneous, hyper-synchronized neuronal bursting.

5.2 GABAergic Failure and Disinhibition

The flip side of glutamatergic hyper-excitability in the kindling cascade is the progressive breakdown of endogenous inhibitory control, mediated by the gamma-aminobutyric acid (GABA) system. In healthy corticolimbic networks, excitatory pyramidal projection neurons are tightly constrained by an intricate network of local inhibitory interneurons, most notably the fast-spiking, parvalbumin-positive ($PV^+$) basket cells and somatostatin-positive ($SST^+$) interneurons. These GABAergic cells provide powerful feedforward and feedback inhibition, maintaining the delicate excitation/inhibition ($E/I$) balance required for normal emotional processing and cognitive flexibility.

Extensive neurobiological investigations demonstrate that repetitive affective episodes and kindled neural activity exert a devastating toll on these inhibitory networks. Fast-spiking $PV^+$ interneurons possess exceptionally high metabolic rates and are exquisitely vulnerable to oxidative stress and excitotoxic injury. With repeated affective episodes, corticolimbic structures exhibit a marked downregulation of the GABA-synthesizing enzymes, glutamic acid decarboxylase 65 and 67 ($GAD65/67$), leading to a profound reduction in total presynaptic GABA synthesis. In vivo proton magnetic resonance spectroscopy ($^1H-MRS$) studies in patients with recurrent unipolar and bipolar depression consistently demonstrate robust, stage-dependent reductions in absolute GABA concentrations within the anterior cingulate cortex, medial prefrontal cortex, and occipital cortex.

Furthermore, post-synaptic $GABA_A$ receptor architecture undergoes pathological remodeling. The subunit composition of $GABA_A$ receptors shifts, often exhibiting a loss of the classic $\alpha_1$ subunits that mediate fast, phasic inhibition, alongside reductions in $\gamma_2$ subunits necessary for receptor anchoring at the post-synaptic density. Perhaps most alarmingly, repetitive severe depolarization can lead to a functional downregulation or reversal of the potassium-chloride cotransporter 2 (KCC2). When KCC2 is depleted, intracellular chloride ($[Cl^-]_i$) accumulates inside the post-synaptic neuron. Consequently, when GABA binds to its receptor, chloride ions flow *out* of the cell rather than inward, converting what should be a hyperpolarizing, inhibitory signal into a depolarizing, excitatory discharge. The nervous system loses its master brake, paving the way for unchecked kindled propagation across the limbic axis.

5.3 Monoaminergic Dysregulation Across Progressive Stages

While classic monoaminergic theories were insufficient to explain the longitudinal course of affective disorders, monoaminergic systems (serotonin, norepinephrine, and dopamine) play a crucial role as modulators and downstream effectors of the kindling and sensitization cascade. Rather than remaining static, the sensitivity and structural organization of monoaminergic networks undergo profound, stage-specific transformations across progressive episode recurrences.

The serotonergic ($5-HT$) system, originating in the midbrain dorsal and median raphe nuclei, exhibits progressive functional exhaustion across multiple affective episodes. In early-stage illness, acute stress evokes compensatory increases in serotonergic firing and upregulates $5-HT_{1A}$ autoreceptor signaling. However, as kindling proceeds, sustained corticolimbic excitotoxicity and chronically elevated glucocorticoids induce a permanent desensitization and transcriptional downregulation of somatodendritic $5-HT_{1A}$ receptors and post-synaptic $5-HT_{2A}$ receptors throughout the hippocampus and prefrontal cortex. This blunts the neuroprotective and neurotrophic signaling normally mediated by serotonin, leaving the limbic system defenseless against excitotoxic stress.

The noradrenergic system, orchestrated by the pontine locus coeruleus, exhibits a trajectory marked by initial hyper-reactivity followed by metabolic and structural depletion. In early episodes, locus coeruleus neurons fire paroxysmally in response to environmental stressors, showering the basolateral amygdala with norepinephrine, activating $\beta$-adrenergic receptors, and consolidating the traumatic memory traces that drive behavioral sensitization. Over repeated cycles, however, this hyper-adrenergic state exhausts tyrosine hydroxylase reserves and degrades $\alpha_2$-adrenergic autoinhibitory mechanisms. Concurrently, the dopaminergic system undergoes progressive sensitization, particularly in bipolar diatheses. Sensitized dopamine $D_2$ and $D_3$ receptors in the ventral striatum and prefrontal cortex drive the psychomotor agitation, grandiosity, and flight of ideas characteristic of manic episodes. The profound dysregulation of these three monoaminergic systems feeds directly back into the structural limbic remodeling, reinforcing the kindled state.

6. Neuroplasticity, Immediate Early Genes, and Epigenetic Mechanisms

6.1 Immediate Early Gene Activation Cascades

To understand how transient, fleeting episodes of affective dysregulation are permanently converted into enduring biological traits, the kindling framework delves into the domain of molecular neurobiology and genomic transcription. When a corticolimbic neuron is subjected to intense depolarizing stimuli or severe neurochemical stress, the intracellular influx of calcium and activation of second-messenger systems (such as cyclic adenosine monophosphate, cAMP, and protein kinase A, PKA) triggers the near-instantaneous transcription of a specialized class of genes known as immediate early genes (IEGs).

Within minutes of episode-related stress, IEGs such as c-Fos, c-Jun, zif268 (also known as Egr-1), and Fra-2 are transcribed in vast quantities throughout the basolateral amygdala, the dentate gyrus of the hippocampus, and the medial prefrontal cortex. These IEGs do not code for structural proteins or ion channels directly; instead, their protein products function as inducible transcription factors. The Fos and Jun protein families undergo dimerization to form the activator protein-1 (AP-1) transcription factor complex. The AP-1 complex then translocates to the cell nucleus, where it binds to specific regulatory DNA sequences (AP-1 binding sites) located in the promoter and enhancer regions of a broad spectrum of “late” effector target genes.

This genomic cascade represents the molecular gateway from acute, transient functional activity to permanent cellular phenotypic change. The late effector genes regulated by the AP-1 complex code for neuropeptides, structural cytoskeletal proteins (such as tubulin and actin), neurotrophin receptors, ion channel subunits, and enzymes responsible for neurotransmitter synthesis. Through this mechanism, every single affective episode initiates a massive, coordinated alteration in the structural and functional proteome of the affected neurons. Over multiple affective recurrences, the persistent induction of stable transcription factors—most notably the highly stable, truncated splice variant $\Delta FosB$, which resists degradation and accumulates over weeks to months—locks the corticolimbic architecture into a permanently modified, kindled state.

6.2 Neurotrophic Factor Depletion and Synaptic Atrophy

A central pillar of modern neuroplasticity models of affective progression is the severe disruption of endogenous neurotrophic support, mediated primarily by brain-derived neurotrophic factor (BDNF). Under physiological conditions, BDNF binds to its high-affinity receptor, tropomyosin receptor kinase B (TrkB), initiating downstream intracellular signaling cascades—including the MAPK/ERK, PI3K/Akt, and PLC$\gamma$ pathways—that promote neuronal survival, synaptic plasticity, dendritic branching, and adult hippocampal neurogenesis.

During acute depressive episodes, as well as during prolonged states of distress and excitotoxicity, there is a marked, profound downregulation of BDNF gene expression, driven in part by stress-induced glucocorticoid receptor signaling and CREB phosphorylation failure. This collapse of neurotrophic support exerts immediate structural consequences upon vulnerable limbic regions. In the CA3 region of the hippocampus, pyramidal neurons undergo dramatic dendritic retraction, with extensive loss of apical dendritic branching and a devastating loss of synaptic spines—the primary sites of excitatory synaptic contact. Similar patterns of synaptic pruning, dendritic atrophy, and neuropil loss occur in the layer II/III pyramidal neurons of the dorsolateral prefrontal cortex and anterior cingulate cortex.

Concurrently, neurogenesis within the subgranular zone (SGZ) of the dentate gyrus in the adult hippocampus is profoundly suppressed. This loss of neurogenic replenishment compromises the dentate gyrus’s critical computational function of “pattern separation,” impairing the brain’s ability to distinguish between dangerous and safe contexts, thereby entrenching the behavioral sensitization to stress. Longitudinal neuroimaging studies in recurrent affective disorders confirm this neurodegenerative aspect: there is a direct, linear correlation between the cumulative lifetime number of depressive or manic episodes and the magnitude of progressive gray matter volumetric loss in the hippocampus and prefrontal cortex.

6.3 Epigenetic Modifications in Illness Progression

The ultimate consolidation of the kindled affective phenotype occurs within the chromatin architecture itself, governed by sophisticated epigenetic modifications. Epigenetics provides the biological missing link explaining how environmental life events can permanently alter gene expression profiles without mutating the underlying nucleotide sequence of DNA. The kindling and sensitization cascade utilizes three primary, interacting epigenetic mechanisms: DNA methylation, histone post-translational modifications, and non-coding RNA regulation.

During severe early-life trauma and successive affective episodes, chromatin remodeling enzymes are recruited to critical regulatory loci throughout the corticolimbic genome. For instance, the promoter region of the nuclear receptor subfamily 3 group C member 1 (NR3C1) gene, which encodes the glucocorticoid receptor (GR), undergoes de novo hypermethylation by DNA methyltransferases (DNMTs). This hypermethylation prevents the binding of transcription factors, resulting in a persistent, long-term downregulation of glucocorticoid receptors in the hippocampus, which permanently dismantles the negative feedback loop of the hypothalamic-pituitary-adrenal (HPA) axis.

Simultaneously, post-translational modifications of histone tails act as stable cellular markers of disease progression. Repetitive affective stress induces the deacetylation of histone H3 and H4 tails via histone deacetylases (HDACs), compacting the chromatin structure into an inaccessible heterochromatin state that represses neuroprotective genes, such as the Bdnf exon IV promoter. Concurrently, repressive histone methylation marks, such as trimethylation of histone H3 lysine 9 ($H3K9me3$) and lysine 27 ($H3K27me3$), are deposited across genomic domains that support synaptic plasticity. These epigenetic alterations act as a stable “transcriptional memory” of prior affective episodes. With each subsequent relapse, the epigenetic landscape becomes progressively more locked into a pathological state, cementing episode autonomy and providing a molecular rationale for why mood stabilizers that possess direct epigenetic targets (such as valproate, a potent HDAC inhibitor) exhibit unique therapeutic efficacy.

7. Stress-Diathesis Interactions and the Transition to Episode Autonomy

7.1 HPA Axis Hyperactivity and Glucocorticoid Resistance

The neuroendocrine manifestation of the kindling trajectory is seen in the progressive, intractable dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. In healthy individuals, an acute stressor provokes the release of corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) from the parvocellular neurons of the hypothalamic paraventricular nucleus (PVN). This stimulates the anterior pituitary to secrete adrenocorticotropic hormone (ACTH), which in turn prompts the adrenal cortex to synthesize and release cortisol. Cortisol terminates this stress cascade by binding to high-affinity mineralocorticoid receptors (MR) and lower-affinity glucocorticoid receptors (GR) in the hippocampus and PVN, exerting robust negative feedback.

In recurrent affective illness, this delicate homeostatic feedback loop undergoes catastrophic structural breakdown. As episodes recur, sustained hypercortisolemia downregulates hippocampal MR and GR densities. In accordance with Robert Sapolsky’s classic “glucocorticoid neurotoxicity hypothesis,” the loss of hippocampal GRs diminishes the hippocampus’s ability to exert inhibitory control over the hypothalamus. The brake is effectively removed from the system. This results in feed-forward, runaway hyper-secretion of CRH and cortisol, manifesting clinically as non-suppression on the dexamethasone suppression test (DST) and the highly sensitive combined DEX-CRH test.

Over time, the chronic bombardment of peripheral and central tissues by glucocorticoids induces systemic “glucocorticoid resistance.” Glucocorticoid receptors become functionally uncoupled from their nuclear chaperones and downstream signaling elements. Consequently, high circulating levels of cortisol can no longer exert their normal anti-inflammatory and homeostatic actions. Unconstrained CRH networks within the central nucleus of the amygdala and the bed nucleus of the stria terminalis (BNST) become hyper-functional, firing persistently and driving subjective states of severe autonomic arousal, anhedonia, and psychic panic, even when the patient is resting in an objectively non-threatening environment.

7.2 Inflammatory Cascades and Microglial Priming

One of the most consequential modern extensions of Robert M. Post’s kindling framework is the recognition that neuroinflammation acts as a primary, perpetuating mediator of the kindling cascade. In the early stages of affective illness, psychological stress mobilizes the innate immune system via sympathetic nervous system outflow, stimulating peripheral monocytes and tissue macrophages to release pro-inflammatory cytokines, including interleukin-1 beta ($IL-1\beta$), interleukin-6 ($IL-6$), and tumor necrosis factor-alpha ($TNF-\alpha$).

With repeated affective recurrences, these circulating peripheral cytokines breach the blood-brain barrier (BBB) via areas of increased permeability, carrier-mediated transport, and vagal afferent signaling. Once inside the central nervous system, cytokines directly interact with the brain’s resident immune cells: the microglia. Microglia undergo a profound transformation from their resting, highly ramified, homeostatic surveying phenotype into an activated, amoeboid, pro-inflammatory (classic M1-like) state. Most critically, repetitive affective episodes induce the phenomenon of “microglial priming.” Primed microglia do not fully return to their baseline quiescent state during clinical euthymia; instead, they remain in a state of chronic, heightened readiness.

When an individual with primed microglia encounters even a trivial stressor, these immune cells release massive, disproportionate surges of cytotoxic cytokines, ROS, and reactive nitrogen species directly into the neurophil. Furthermore, neuroinflammation dramatically accelerates glutamatergic kindling via the kynurenine pathway. Inflammatory cytokines activate the enzyme indoleamine 2,3-dioxygenase (IDO) in microglia and astrocytes, shunting dietary tryptophan away from serotonin synthesis and into the kynurenine metabolic cascade. This leads to the massive accumulation of quinolinic acid—a potent, endogenous NMDA receptor agonist that directly causes excitotoxic neuronal death and synaptic pruning. Conversely, the synthesis of kynurenic acid—an endogenous NMDA receptor antagonist produced by astrocytes—is suppressed. The resulting neurochemical milieu is intensely neurotoxic, accelerating the kindling cascade and cementing the progression toward treatment resistance.

7.3 The Threshold Shift to Autonomous Cellular Firing

The ultimate culmination of the kindling cascade—the transition from triggered episodes to complete biological autonomy—is fundamentally an electrophysiological and biophysical event. How does a neuronal network, originally dependent upon external synaptic inputs driven by psychosocial stressors, transition into a state where it generates spontaneous, rhythmic, syndromal affective episodes? Computational neuroscience and biophysical investigations provide compelling mechanistic answers centered on intrinsic membrane excitability and microcircuit remodeling.

Under the cumulative influence of glutamatergic excitotoxicity, GABAergic disinhibition, neurotrophic collapse, and neuroinflammation, the biophysical membrane properties of corticolimbic projection neurons undergo fundamental shifts. Key among these is the remodeling of voltage-gated ion channels. Neurons exhibit a pathological upregulation of persistent, non-inactivating sodium currents ($I_{NaP}$) and a marked downregulation of low-threshold, A-type potassium currents ($I_A$) and inward-rectifying potassium channels ($K_{ir}$). This disruption in the balance of subthreshold intrinsic conductances dramatically alters the neuron’s input-output transfer function: the resting membrane potential drifts closer to the action potential threshold, and the cell exhibits somatic-dendritic decoupling, wherein weak dendritic inputs trigger massive, repetitive, high-frequency axonal burst firing.

Furthermore, pacemaking channel systems undergo extensive remodeling. Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, which generate the hyperpolarization-activated inward current ($I_h$) that governs rhythmic oscillations in the hippocampus and amygdala, become dysregulated. As intrinsic membrane conductances become persistently hyper-excitable, local circuits develop self-sustaining reverberating loops. The corticolimbic network forms what computational psychiatrists term “pathological attractor states.” Once trapped within a pathological attractor basin, the network requires no external afferent push to initiate an episode; the intrinsic, kindled microcircuit oscillates spontaneously between the extreme boundaries of severe depressive shutdown and unconstrained manic firing. Autonomy is fully realized.

8. Pharmacological Implications: Anticonvulsants and Mood Stabilizers

8.1 Differential Efficacy Across Illness Stages

The most profound clinical validation of Robert M. Post’s kindling model is found in the differential psychopharmacological responsiveness of affective disorders across their longitudinal lifespan. Rather than exhibiting uniform therapeutic efficacy throughout all phases of disease, mood-stabilizing agents demonstrate striking, stage-dependent variations in efficacy that align precisely with the predictions of kindling and sensitization theory.

Lithium carbonate, the historic gold standard of bipolar pharmacotherapy, exhibits its absolute greatest efficacy during the early, non-kindled stages of the illness. Clinical trials and naturalistic longitudinal studies consistently demonstrate that lithium is exceptionally potent when initiated following the first or second lifetime manic episode, particularly in patients presenting with classical bipolar I disorder characterized by discrete, euphoric manic episodes followed by clear well intervals and complete inter-episode recovery. However, if lithium therapy is delayed until the patient has experienced dozens of recurrent episodes, or once the illness has advanced into rapid cycling, continuous cycling, or mixed states, lithium’s prophylactic response rate plummets dramatically—often dropping from over 70% in early stages to below 20% in late, kindled stages.

Conversely, anticonvulsant mood stabilizers—specifically carbamazepine and valproic acid (divalproex sodium)—demonstrate their most dramatic clinical utility in precisely those advanced, kindled states where lithium fails. Patients with rapid cycling bipolar disorder, dysphoric or mixed mania, secondary affective illness, and high lifetime episode counts show robust clinical responsiveness to these anticonvulsant agents. This striking pharmacological dissociation provides powerful evidence for the kindling hypothesis: the molecular mechanisms required to halt early, non-kindled disease (where lithium acts via GSK-3$\beta$ inhibition, inositol depletion, and neurotrophic rescue) diverge significantly from the biophysical mechanisms required to arrest advanced, kindled disease (where anticonvulsants directly suppress voltage-gated ion channels and pathological network synchronization).

8.2 Mechanisms of Carbamazepine and Valproate

The rationale for Robert M. Post’s introduction of carbamazepine and valproate into psychiatric therapeutics emerged directly from their demonstrated capacity to block experimental kindling in Goddard’s animal paradigms. In the laboratory, both carbamazepine and valproate display potent “anti-kindling” properties: they suppress the development of electrographic afterdischarges, prevent the spread of seizure activity from the limbic focus to generalized motor networks, and, most crucially, block the spontaneous seizures of fully kindled animals.

The precise molecular mechanisms of these anticonvulsant agents mirror the pathophysiological defects of the kindled state:

• Voltage-Gated Sodium Channel Blockade: Carbamazepine binds with high affinity to the inactivated state of voltage-gated sodium channels ($Na_V1.1, Na_V1.2, Na_V1.6$). By prolonging the refractory period of these channels, carbamazepine selectively suppresses high-frequency, sustained, repetitive neuronal firing without interfering with normal, low-frequency physiological neurotransmission. This mechanism directly dampens the pathological paroxysmal depolarizing shifts occurring within kindled amygdalo-prefrontal circuits.
• Potentiation of GABAergic Inhibition: Valproic acid dramatically amplifies central inhibitory tone through multifaceted mechanisms. It inhibits the primary GABA-degrading enzymes, GABA transaminase (GABA-T) and succinate semialdehyde dehydrogenase (SSADH), while concurrently stimulating the activity of glutamic acid decarboxylase (GAD), the rate-limiting enzyme in GABA synthesis. This dual action floods the synaptic and extrasynaptic space with GABA, restoring feedforward and feedback inhibition in disinhibited limbic networks.
• Direct Epigenetic Chromatin Remodeling: Beyond its membrane and metabolic effects, valproic acid is a potent, direct inhibitor of Class I and Class IIa histone deacetylases (HDACs). By inhibiting HDACs, valproate increases global histone H3 and H4 acetylation, unraveling condensed heterochromatin and robustly reactivating the transcription of critical neuroprotective genes, including BDNF, Bcl-2 (a master anti-apoptotic regulator), and various neuroprotective heat shock proteins. Valproate thus directly counteracts the repressive epigenetic marks deposited by prior affective episodes.

8.3 Antikindling Properties of Atypical Antipsychotics and Novel Agents

The pharmacological armamentarium targeting kindled affective pathology has expanded significantly beyond classical anticonvulsants, encompassing second- and third-generation atypical antipsychotics as well as novel glutamatergic agents. Atypical antipsychotics, such as quetiapine, olanzapine, aripiprazole, and lumateperone, have emerged as first-line mood stabilizers that possess potent anti-kindling and anti-sensitization properties.

At the receptor level, these agents combine varying degrees of dopamine $D_2$ receptor partial or full antagonism with potent serotonin $5-HT_{2A}$ and $5-HT_{1A}$ receptor modulation. By blocking post-synaptic $5-HT_{2A}$ receptors, atypical antipsychotics directly suppress stress-induced glutamate release in the prefrontal cortex, dampening the excitotoxic cascade. Their modulation of dopaminergic signaling blunts the expression of behavioral sensitization, halting the progression of psychomotor acceleration and affective psychosis. Furthermore, atypical antipsychotics exert robust anti-inflammatory effects: they suppress microglial activation, downregulate the secretion of $IL-1\beta$ and $TNF-\alpha$, and stimulate the release of neurotrophic factors, thereby shielding vulnerable limbic microcircuits from the neurotoxic consequences of acute affective storms.

Perhaps the most revolutionary recent development in anti-kindling therapeutics is the clinical introduction of rapid-acting glutamatergic modulators, specifically the non-competitive NMDA receptor antagonist ketamine and its enantiomer, esketamine. In contrast to conventional monoaminergic antidepressants, which require weeks to elicit clinical responses and carry high risks of cycle acceleration in bipolar cohorts, ketamine delivers rapid, profound antidepressant and anti-suicidal effects within hours. Ketamine acts as a chemical “circuit breaker”: by transiently blocking NMDA receptors on GABAergic interneurons, it produces a burst of glutamate that preferentially activates AMPA receptors, triggering immediate, massive releases of BDNF, activating the mammalian target of rapamycin complex 1 (mTORC1) pathway, and rapidly restoring the dendritic spines and synaptic connections that were destroyed by prior kindling episodes.

9. Clinical Staging Models Derived from the Kindling Framework

9.1 Structural Staging Criteria in Bipolar Disorder

The enduring clinical legacy of Robert M. Post’s kindling theory is reflected in the modern architectural paradigm of psychiatric diagnosis: clinical staging. Historically, psychiatric diagnostic manuals (such as the DSM and ICD) have employed rigid, cross-sectional, categorical criteria that treat a disorder as either present or absent, completely ignoring the patient’s longitudinal trajectory. In response to this limitation, Post’s framework inspired contemporary psychiatric leaders—most notably Michael Berk, Flavio Kapczinski, and Patrick McGorry—to develop comprehensive structural staging criteria for bipolar and major depressive disorders.

These staging models conceptualize affective illness along a biological and phenomenological continuum, mapping directly onto the progression from behavioral sensitization to electrophysiological kindling and autonomous firing:

• Stage 0 (At-Risk / Asymptomatic): Individuals possess a high familial or genetic vulnerability (e.g., first-degree relatives of bipolar probands) but currently manifest no clear psychiatric symptomatology. Biomarkers show subtle, latent alterations in neuroendocrine stress reactivity.
• Stage 1 (Prodromal / Attenuated Syndrome): Characterized by non-specific, sub-syndromal mood fluctuations, mild dysthymia, anxiety, sleep disturbances, and behavioral sensitization to life stress. Synaptic plasticity remains intact, and neuroimaging reveals minimal structural loss.
• Stage 2 (First Syndromal Episode): The patient experiences their first fully syndromal, DSM-criteria major depressive, manic, or mixed episode, almost universally precipitated by a severe psychosocial stressor. This stage represents the critical therapeutic crossroads where full-dose, neuroprotective mood stabilization can halt the kindling trajectory.
• Stage 3 (Recurrent Episodes / Incomplete Inter-Episode Recovery): Marked by repeated affective relapses, progressive cycle compression, and the transition toward episode autonomy. Identifiable life events decline as precipitants. The patient begins to manifest persisting sub-syndromal symptoms, executive dysfunction, and neuroimaging demonstrates measurable gray matter volumetric loss in the hippocampus and prefrontal cortex.
• Stage 4 (Chronic / Autonomous / Treatment-Refractory): The terminal, kindled state characterized by intractable rapid cycling, continuous unremitting affective symptoms, severe neurocognitive dementia-like decline, loss of social and occupational autonomy, and multi-drug treatment refractoriness. Extensive corticolimbic atrophy, chronic neuroinflammation, and profound connectomic fragmentation are evident.

9.2 Prophylaxis and the Principle of Early Intervention

The practical implication of this clinical staging continuum is what Post termed the “neuroprotective imperative” of early intervention. In traditional medicine—such as oncology, cardiology, and diabetology—the absolute standard of care is to detect disease at Stage 1 or 2 and intervene aggressively to prevent progression to Stage 3 or 4. Tragically, clinical psychiatry historically embraced a passive, reactionary approach, often delaying the initiation of definitive mood-stabilizing prophylaxis until a patient had suffered multiple catastrophic relapses, ruined their interpersonal and financial life, or survived severe suicide attempts.

The kindling model demonstrates that every single untreated affective episode is a biological disaster for the central nervous system. Affective episodes are inherently neurotoxic events that drive excitotoxicity, oxidative stress, epigenetic silencing of neurotrophins, and microglial priming. Therefore, allowing a patient to experience recurrent affective episodes under the misguided assumption that one should “wait and see” if another episode occurs is biologically equivalent to allowing repeated subthreshold electrical shocks to propagate through their temporal lobes. Prophylaxis must be instituted early, decisively, and maintained continuously.

Furthermore, the kindling framework provides a stark warning regarding the hazards of treatment discontinuation. Clinical trials consistently demonstrate that when patients with well-controlled bipolar disorder abruptly discontinue their mood-stabilizing medications (such as lithium), their relapse rate is significantly higher than would be predicted by the natural history of their untreated illness alone. Even more chillingly, Post and colleagues documented that a substantial subset of patients who were perfectly maintained on lithium, discontinue it, suffer a kindled relapse, and then restart the exact same dose of lithium, *fail to regain their prior therapeutic response*. The neurobiological re-kindling that occurred during the drug-free relapse fundamentally reshapes the corticolimbic substrate, transforming a formerly lithium-responsive illness into a lithium-refractory condition.

9.3 Biomarkers of Stage Progression

To transition clinical staging from a theoretical construct into an objective, laboratory-guided discipline, intensive research has focused on identifying circulating and imaging-based biomarkers that track the kindling progression across stages. These biomarkers capture the molecular scars left behind by cumulative affective episodes, providing objective indices of biological age and disease burden.

In peripheral blood, neurotrophic trajectories serve as sensitive staging markers. Circulating serum and plasma BDNF concentrations exhibit a stage-dependent collapse: while BDNF levels are often moderately reduced during acute episodes in Stage 2 and normalize entirely during euthymia, patients in Stage 3 and 4 display profoundly depressed baseline BDNF levels that fail to recover even when affective symptoms transiently abate. Concurrently, markers of chronic, systemic low-grade inflammation and oxidative damage systematically escalate across stages. Serum levels of pro-inflammatory cytokines ($IL-6, TNF-\alpha, IL-1\beta$), high-sensitivity C-reactive protein (hs-CRP), and markers of macromolecular oxidative injury—such as 8-hydroxy-2′-deoxyguanosine (8-OHdG, indicating oxidative DNA damage) and malondialdehyde (MDA, indicating lipid peroxidation)—correlate directly with the lifetime number of manic and depressive episodes.

In structural and functional neuroimaging, high-resolution 3T and 7T magnetic resonance imaging (MRI) reveals progressive volumetric thinning that mirrors the kindling timeline. Patients exhibit accelerated gray matter loss localized to the hippocampus, amygdala, ventral anterior cingulate cortex (ACC), and dorsolateral prefrontal cortex (DLPFC). Advanced functional connectomics further demonstrates that with advancing stage, the functional connectivity between the prefrontal executive control networks and the subcortical limbic networks degrades, replaced by hyper-synchronized, pathological connectivity within the default mode network (DMN). The brain’s structural connectome becomes physically fragmented, confirming the extensive morphological remodeling predicted by Post’s kindling theory.

10. Diagnostic and Therapeutic Challenges: Rapid Cycling and Treatment Resistance

10.1 The Pathobiology of Treatment Resistance

One of the most vexing dilemmas in neuropsychiatry is the emergence of treatment-resistant affective illness. Why do pharmacological agents that once provided robust, sustained symptom relief gradually lose their therapeutic efficacy in late-stage illness? The kindling model provides a rigorous pathophysiological framework for deciphering this multi-drug resistant state, demonstrating that treatment refractoriness is the direct biological consequence of advanced, unchecked neuroplastic remodeling.

At the blood-brain barrier (BBB), chronic neuroinflammation and repetitive metabolic stress induce the upregulation of ATP-binding cassette (ABC) transporter proteins, most notably P-glycoprotein (P-gp / ABCB1). These membrane-bound efflux pumps actively extrude a wide variety of lipophilic psychotropic medications out of the cerebral capillary endothelial cells and back into the systemic circulation, preventing effective therapeutic drug concentrations from ever penetrating the brain parenchyma. The brain literally builds a biochemical fortress that excludes the very pharmacological tools designed to heal it.

Intracellularly, treatment resistance is driven by the profound degradation of downstream signal transduction cascades. Decades of kindled excitotoxicity uncouple post-synaptic receptors from their heterotrimeric G-proteins, deplete critical intracellular second messengers (such as cyclic AMP and myo-inositol), and induce severe bioenergetic mitochondrial decay. Even if a mood-stabilizing or antidepressant molecule successfully binds to its target cell-surface receptor, the intracellular machinery required to translate that receptor occupancy into neuroprotective gene transcription—via CREB, Wnt/$\beta$-catenin, or BDNF-TrkB signaling—is broken. The synapse suffers from structural uncoupling: extensive dendritic spine loss and synaptic pruning sever the physical pathways of communication, leaving the corticolimbic network functionally fragmented and therapeutically inaccessible to monotherapy.

10.2 Management Strategies for Kindled Refractory States

Managing an advanced, kindled, treatment-refractory affective state demands a sophisticated, multi-targeted therapeutic approach. Monotherapy is virtually never successful in Stage 4 illness; clinicians must deploy rational, mechanically synergistic polypharmacy designed to target multiple nodes of the disordered corticolimbic network simultaneously.

The pharmacological backbone of kindled refractory management relies on the strategic co-administration of agents with non-overlapping mechanisms of action. Combining a voltage-gated sodium channel stabilizer (such as carbamazepine or lamotrigine) with a potent GABA-enhancing, HDAC-inhibiting agent (such as valproate) and an atypical antipsychotic (such as quetiapine or clozapine) provides broad-spectrum suppression of excitotoxicity, restoration of inhibitory tone, and blockade of sensitized dopamine receptors. In cases of intractable rapid cycling, the careful addition of supratherapeutic doses of levothyroxine ($T_4$) has been shown to stabilize disrupted central pacemakers, dampening the rapid metabolic oscillations of the limbic system.

Beyond traditional psychopharmacology, neuromodulation techniques play a central role in resetting kindled circuits. Electroconvulsive therapy (ECT) represents the ultimate biological paradox in kindling therapeutics: although ECT delivers an electrical stimulus that evokes a generalized seizure, its therapeutic efficacy is mediated by its profound, unmatched *anti-kindling* consequences. Following an ECT seizure, the brain deploys massive, compensatory inhibitory cascades—releasing enormous quantities of endogenous GABA, neuropeptide Y (NPY), and adenosine, alongside dramatic upregulations of BDNF and adult neurogenesis. ECT raises the seizure threshold progressively with each treatment, acting as the most powerful anti-kindling modality in clinical medicine. Modern non-invasive neuromodulatory modalities, including repetitive transcranial magnetic stimulation (rTMS) and vagus nerve stimulation (VNS), similarly aim to restore prefrontal-limbic inhibitory connectivity and arrest autonomous affective pacing.

10.3 Iatrogenic Risks: Antidepressant-Induced Sensitization

An essential clinical corollary of Post’s kindling and sensitization framework is the critical identification of iatrogenic harm, specifically the phenomenon of antidepressant-induced destabilization. In clinical practice, unipolar depression and the depressive phases of bipolar disorder are often treated indiscriminately with traditional monoaminergic antidepressant monotherapy, such as tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and serotonin-norepinephrine reuptake inhibitors (SNRIs).

The kindling model demonstrates that in individuals harboring a sensitized corticolimbic diathesis, these pharmacological agents can act as potent pathological catalysts. Chronic, unbuffered exogenous stimulation of monoaminergic receptors can trigger acute manic switching, induce highly dangerous mixed states characterized by simultaneous depressive agony and manic psychomotor activation, and, most ominously, trigger irreversible phase acceleration. Antidepressants can literally “kindle” rapid cycling, transforming an episodic, manageable illness into an intractable, continuous-cycling state that persists long after the offending antidepressant has been discontinued.

The biophysical basis of this iatrogenic destabilization involves the further down-regulation of already compromised inhibitory interneurons and the hyper-sensitization of mesolimbic dopamine circuits. In recognition of these profound risks, major international psychiatric organizations—including the International Society for Bipolar Disorders (ISBD) and the Canadian Network for Mood and Anxiety Treatments (CANMAT)—have integrated Post’s principles into their treatment guidelines. These guidelines strongly discourage the use of antidepressant monotherapy in bipolar disorder, mandate the co-administration of robust anti-kindling mood stabilizers whenever antidepressants are considered, and emphasize the rapid tapering of antidepressants at the earliest sign of cycle acceleration or mixed symptomatology.

11. Critical Appraisals, Limitations, and Counter-Arguments

11.1 Methodological Challenges in Translating Animal Kindling to Human Mood

Despite its vast explanatory power and widespread clinical influence, Robert M. Post’s kindling model has encountered rigorous scientific critique and methodological skepticism over the decades. The primary epistemological challenge rests on the validity of translating an electrophysiological model of motor epilepsy directly into the complex, polymorphous realm of human affective psychopathology.

In Graham Goddard’s classical paradigm, kindling is indexed by concrete, unmistakable, objective physical endpoints: focal motor clonus, tonic-clonic convulsions, and unambiguous, high-amplitude electrographic spike-and-wave discharges recorded directly via intracerebral electrodes. In clinical psychiatry, however, the primary dependent variables are subjective, complex, and linguistically mediated: feelings of worthlessness, existential despair, grandiose ideation, racing thoughts, and suicidal intent. Critics rightly point out that an affective episode is not an overt seizure. Standard scalp electroencephalography (EEG) in patients experiencing acute melancholia or manic delirium typically reveals non-specific dysrhythmias, diffuse slowing, or normal cerebral rhythms—not the organized, high-voltage epileptiform paroxysms that define true electrophysiological kindling.

Furthermore, significant species-specific limitations complicate this translation. Experimental kindling is typically conducted in the lissencephalic brains of rodents, which lack the massive, highly developed neocortical architecture, particularly the granular dorsolateral prefrontal cortex, that defines the human brain and provides top-down cognitive control over emotional behavior. Reproducing genuine, spontaneous, recurrent affective polarity switches in animal models has proven notoriously elusive. While animals can be rendered chronically anxious, anhedonic, or motorically hyperactive, no animal model faithfully captures the spontaneous, cyclical oscillation between mania and depression that characterizes human bipolar illness, leaving the kindling model as a powerful heuristic and metaphorical framework, but one that faces distinct translational gaps at the biophysical level.

11.2 Epidemiological and Empirical Discrepancies

From an epidemiological perspective, several prominent psychiatric researchers have challenged the universal applicability of the kindling model, arguing that it overstates the inevitability of clinical and biological deterioration. While naturalistic cohorts often demonstrate cycle acceleration, large-scale, population-based longitudinal studies have demonstrated that the course of recurrent affective illness exhibits profound clinical heterogeneity that cannot be neatly compressed into a single kindling trajectory.

A substantial subset of patients diagnosed with recurrent major depressive disorder or bipolar disorder does *not* display systematic cycle acceleration. Instead, their illness follows a stable, linear course characterized by uniform well intervals that do not contract over decades, or even an episodic course that displays spontaneous amelioration and cycle deceleration as they reach senescence. Critics have highlighted the significant confounding role of recall bias in retrospective studies of life events. Patients currently experiencing severe, unprovoked affective episodes are prone to “effort after meaning,” selectively searching their past to identify early environmental traumas while under-reporting minor stressors that may have preceded later episodes, artificially inflating the apparent transition from “triggered” to “spontaneous” illness.

Moreover, methodologists argue that the apparent worsening of illness course observed in tertiary academic research centers (such as the NIMH Biological Psychiatry Branch) represents an artifact of referral and selection bias—known as Berkson’s bias. The patients who accumulate in specialized academic clinics are precisely the most severe, treatment-refractory, rapid-cycling individuals in the population. Following these enriched cohorts longitudinally risks mistaking the malignant trajectory of an atypical, highly severe clinical subset for the universal natural history of the entire disease entity.

11.3 Competing Theoretical Frameworks

The kindling model does not exist in a theoretical vacuum; it faces formidable competition from alternative, highly robust neurobiological frameworks that offer divergent explanations for the progression of affective illness:

• The Allostatic Load Model: Championed by Bruce McEwen, this paradigm posits that the progressive physical and mental deterioration seen in affective illness is driven by cumulative “wear and tear” on multisystem physiology. Allostatic load attributes disease progression not to localized limbic kindling, but to the collective systemic failure of cardiovascular, metabolic, neuroendocrine, and inflammatory networks operating in concert across decades.
• Circadian Pacemaker and Social Zeitgeber Theory: Formulated by Ellen Frank and David Kupfer, this framework identifies the core pathology of affective illness in the fundamental instability of the master molecular clock located within the hypothalamic suprachiasmatic nucleus (SCN). Episode recurrence and cycle acceleration are conceptualized not as electrical kindling, but as the progressive decoupling of internal circadian rhythms from external social time-givers (“zeitgebers”), driving desynchronization of core body temperature, melatonin secretion, and sleep architecture.
• Pure Neurodevelopmental Models: These paradigms argue that the vulnerability to severe affective illness is largely determined and fixed early in life through aberrant neural migration, disrupted synaptic pruning, and genetic channelopathies during gestation and early childhood. Subsequent affective episodes are viewed merely as the phenotypic expression of an already fractured neurodevelopmental blueprint, rather than an active, episode-driven neurodegenerative process.
• Modern Connectopathy and Network Dynamism: Emerging from computational psychiatry, this view conceptualizes affective disorders as functional and structural connectopathies. Rather than kindling within isolated limbic nodes, mood episodes represent transitions between dynamic, metastable states across whole-brain neural ensembles, governed by non-linear chaos and complex network mathematics.

12. Contemporary Relevance and Future Horizons in Neuropsychiatric Research

12.1 Integration with High-Throughput Omics and Connectomics

Despite these critical debates, the foundational principles of Robert M. Post’s kindling model have found breathtaking validation and revitalization through twenty-first-century cutting-edge neurotechnologies. High-throughput multi-omics and advanced macro-connectomics have provided the ultra-high-resolution tools required to confirm that affective episodes do, in fact, leave lasting, progressive molecular and structural footprints upon the human brain.

Large-scale Genome-Wide Association Studies (GWAS) conducted by the Psychiatric Genomics Consortium (PGC), encompassing hundreds of thousands of patient cohorts, have identified robust, genome-wide significant risk loci that map directly onto the molecular machinery of kindling. Prominent among these are single-nucleotide polymorphisms (SNPs) within CACNA1C (encoding the $\alpha_{1C}$ subunit of the Cav1.2 L-type voltage-gated calcium channel), ANK3 (encoding ankyrin-G, which clusters sodium and potassium channels at the axon initial segment), and various glutamate receptor subunits. These discoveries confirm that genetic susceptibility to bipolar disorder and recurrent depression is fundamentally rooted in the molecular architecture of membrane excitability and synaptic plasticity.

Concurrently, single-cell RNA sequencing (scRNA-seq) of post-mortem human brain tissue has begun to resolve the cell-type-specific transcriptomic signatures of cumulative illness burden. These studies demonstrate progressive, episode-dependent downregulations of myelination-related genes in oligodendrocytes, persistent inflammatory transcriptomic shifts in microglia, and loss of synaptic integrity transcripts in deep-layer cortical pyramidal neurons. In parallel, resting-state functional MRI connectomics has mapped the network-level manifestations of kindling: with increasing lifetime episode count, the brain undergoes progressive “network segregation collapse,” wherein the rich-club hierarchical architecture of the connectome dissolves, rendering the brain exquisitely susceptible to paroxysmal, global functional destabilization.

12.2 Personalized Medicine and Biomarker-Guided Therapeutics

The contemporary clinical renaissance of the kindling model resides in its power to guide the emerging era of personalized, precision psychiatry. As medicine transitions away from imprecise trial-and-error prescribing, the kindling-derived clinical staging framework provides an objective roadmap for stratifying patients into biologically homogeneous cohorts matched to stage-specific therapeutic interventions.

Rather than selecting medications based solely on cross-sectional symptom checklists, future clinical workflows will utilize composite biomarker panels—incorporating genomic risk scores for ion channelopathies, serum BDNF/inflammatory cytokine ratios, and resting-state frontolimbic functional connectivity metrics—to determine a patient’s precise biological stage. An individual identified at Stage 1 or early Stage 2 can be prioritized for neuroprotective monotherapies (such as lithium or targeted psychotherapy) designed to arrest the kindling trajectory before neuroplastic consolidation occurs. Conversely, patients presenting with Stage 3 or 4 biomarkers can be steered immediately toward rational combination pharmacotherapy, epigenetic modulators, or neuromodulatory interventions, bypassing years of ineffective sequential monotherapies.

Furthermore, the digital revolution has provided the ultimate tool for capturing the behavioral sensitization and kindling trajectory in real time: digital phenotyping. By passively and continuously tracking an individual’s digital footprint via smartphone sensors and wearable biosensors—monitoring micro-alterations in typing cadence, voice acoustic dynamics, sleep-wake motor activity, and GPS-derived spatial mobility patterns—machine learning algorithms can detect the earliest, sub-clinical micro-oscillations of affective destabilization. Intervening at the level of these digital subthreshold perturbations allows clinicians to deploy preemptive pharmacological and behavioral micro-interventions, aborting the nascent episode before it can deliver its neurotoxic payload to the corticolimbic network.

12.3 The Lasting Legacy of Robert M. Post’s Theoretical Contributions

The conceptual framework articulated by Robert M. Post stands as one of the most transformative intellectual achievements in the history of neuropsychiatry. By importing the rigorous, biophysical principles of electrophysiological kindling and behavioral sensitization into the study of recurrent affective disorders, Post dismantled the artificial, Cartesian divide between the “functional” mind and the “organic” brain that had paralyzed psychiatric medicine for over a century.

Post demonstrated that psychology and biology are merely two different languages describing the exact same underlying reality. Environmental trauma, severe psychosocial grief, and interpersonal conflict are not ephemeral, immaterial experiences; they are profound neurochemical events that alter immediate early gene expression, remodel synaptic architecture, recalibrate ion channel conductances, and physically reshape the human connectome. In doing so, the kindling model delivered a powerful, destigmatizing message to patients and clinicians alike: recurrent affective disorders are not moral failures, personality flaws, or psychological weaknesses; they are dynamic, evolving, and neurobiologically progressive systemic illnesses that demand the same urgency of early diagnosis, aggressive prophylaxis, and sustained scientific investigation as any other major medical condition.

Ultimately, Robert M. Post’s kindling model provided the intellectual foundation that transformed psychiatry from a passive, custodial specialty focused on managing terminal symptom complexes into an active, preventive, and neuroprotective neuroscience. Its overarching principle—that “episodes beget episodes” through cumulative, activity-dependent neuroplastic alterations—remains the guiding light for modern psychiatric research, continuing to inspire novel therapeutic discoveries, international clinical staging guidelines, and a profound, enduring respect for the remarkable, terrifying plasticity of the human brain.

Conclusion

The kindling and behavioral sensitization models developed by Robert M. Post provide a unified, comprehensive neurobiological architecture that accounts for the longitudinal evolution of recurrent unipolar depression and bipolar affective disorder. By tracing the disease trajectory from early, stress-precipitated episodes to autonomous, spontaneous recurrences and rapid-cycling states, the kindling framework exposes the progressive cellular, synaptic, and genomic scars left by recurrent affective storms. The progressive shift from glutamatergic excitotoxicity and GABAergic disinhibition to immediate early gene induction, neurotrophin depletion, and epigenetic remodeling demonstrates that affective disorders are active, neuroplastic processes that induce biological vulnerability over time.

This understanding enforces an urgent prophylactic paradigm in clinical practice. The progressive nature of affective illness demands early, decisive intervention with neuroprotective agents, judicious stewardship of potentially destabilizing medications, and the implementation of multi-targeted, stage-specific treatment strategies. As modern neuropsychiatry continues to integrate high-throughput genomics, molecular imaging, and computational connectomics, Post’s visionary insight—that the central nervous system encodes its own pathological experiences into enduring structural transformations—remains a cornerstone of biological psychopathology, shaping our therapeutic interventions and illuminating the intricate mechanics of the human mind.

References

• Berk, M., Berk, L., Dodd, S., Cotton, S., Macneil, C., Daglas, R., Conus, P., Bech, M., Moylan, S., & Malhi, G. S. (2014). Stage managing bipolar disorder. Bipolar Disorders, 16(5), 471–477. https://doi.org/10.1111/bdi.12099
• Berk, M., Hallam, K. T., & McGorry, P. D. (2007). The potential utility of a staging model as a framework for bipolar disorder. Medical Journal of Australia, 187(S7), S37–S41. https://doi.org/10.5694/j.1326-5377.2007.tb01335.x
• Duman, R. S., & Monteggia, L. M. (2006). A neurotrophic model for stress-related mood disorders. Biological Psychiatry, 59(12), 1116–1127. https://doi.org/10.1016/j.biopsych.2006.02.013
• Goddard, G. V., McIntyre, D. C., & LePiane, K. A. (1969). A permanent change in brain function resulting from daily electrical stimulation. Experimental Neurology, 25(3), 295–330. https://doi.org/10.1016/0014-4886(69)90128-9
• Goodwin, F. K., & Jamison, K. R. (2007). Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression (2nd ed.). Oxford University Press.
• Kapczinski, F., Vieta, E., Andreazza, A. C., Frey, B. N., Gomes, F. A., Tramontina, J., Kauer-Sant’Anna, M., Grassi-Oliveira, R., & Post, R. M. (2008). Allostatic load in bipolar disorder: Implications for pathophysiology and treatment. Neuroscience & Biobehavioral Reviews, 32(4), 672–692. https://doi.org/10.1016/j.neubiorev.2007.10.005
• Kendler, K. S., Thornton, L. M., & Gardner, C. O. (2000). Stressful life events and previous episodes in the etiology of major depression in women: An evaluation of the “kindling” hypothesis. American Journal of Psychiatry, 157(8), 1243–1251. https://doi.org/10.1176/appi.ajp.157.8.1243
• Kraepelin, E. (1921). Manic-Depressive Insanity and Paranoia. E. & S. Livingstone.
• McEwen, B. S. (2000). Allostasis and allostatic load: Implications for neuropsychopharmacology. Neuropsychopharmacology, 22(2), 108–124. https://doi.org/10.1016/S0893-133X(99)00129-3
• Nestler, E. J. (2014). Epigenetic mechanisms of depression. JAMA Psychiatry, 71(4), 454–456. https://doi.org/10.1001/jamapsychiatry.2013.4344
• Post, R. M. (1990). Sensitization and kindling perspectives for the course of affective illness: Toward a new treatment with the carbamazepine and valproate. Pharmacopsychiatry, 23(01), 3–17. https://doi.org/10.1055/s-2007-1014476
• Post, R. M. (1992). Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. American Journal of Psychiatry, 149(8), 999–1010. https://doi.org/10.1176/ajp.149.8.999
• Post, R. M. (2002). Do the neurobiological consequences of unprophylaxed episodes in recurrent affective disorders validate the Kraepelinian vision? Journal of Affective Disorders, 72(2), 127–147. https://doi.org/10.1016/S0165-0327(02)00168-9
• Post, R. M. (2007). Role of kindling and sensitization in the progressive alterations in gene expression and neurobiology of recurrent affective disorders. Dialogues in Clinical Neuroscience, 9(4), 415–432. https://doi.org/10.31887/DCNS.2007.9.4/rmpost
• Post, R. M., & Weiss, S. R. (1989). Sensitization, kindling, and carbamazepine: An update. Journal of Clinical Psychopharmacology, 9(5), 317–319.
• Post, R. M., & Weiss, S. R. (1998). The neurobiology of treatment-resistant mood disorders. In J. F. Greden (Ed.), Foundations of Psychiatric Treatment Resistance (pp. 115–158). American Psychiatric Press.
• Post, R. M., Rubinow, D. R., & Ballenger, J. C. (1986). Conditioning and sensitisation in the longitudinal course of affective illness. British Journal of Psychiatry, 149(2), 191–201. https://doi.org/10.1192/bjp.149.2.191
• Racine, R. J. (1972). Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalography and Clinical Neurophysiology, 32(3), 281–294. https://doi.org/10.1016/0013-4694(72)90177-0
• Sapolsky, R. M. (2000). Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Archives of General Psychiatry, 57(10), 925–935. https://doi.org/10.1001/archpsyc.57.10.925
• Vieta, E., Berk, M., Schulze, T. G., Carvalho, A. F., Suppes, T., Calabrese, J. R., Gao, K., Miskowiak, K. W., & Grande, I. (2018). Bipolar disorders. Nature Reviews Disease Primers, 4(1), 18008. https://doi.org/10.1038/nrdp.2018.8
• Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry, 63(8), 856–864. https://doi.org/10.1001/archpsyc.63.8.856